Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours

Current Opinion in Oncology · Published 2026-06-04 · DOI 10.1097/cco.0000000000001252

Authors (4)

Zahra Noordally, Magdalena Mileva, Alain Hendlisz, Ioannis Karfis

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Noordally, Z., Mileva, M., Hendlisz, A., et al. (2026). Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours. Current Opinion in Oncology. https://doi.org/10.1097/cco.0000000000001252

Related articles

• State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma · Current Opinion in Oncology · 2025 · Same journal
• High-risk smoldering myeloma – a case for early intervention? · Current Opinion in Oncology · 2025 · Same journal
• Artificial intelligence for systemic therapy selection and prediction of outcomes in advanced gynecological cancers · Current Opinion in Oncology · 2026 · Same journal
• Curative strategies for high-risk acute promyelocytic leukemia · Current Opinion in Oncology · 2025 · Same journal
• The evolving landscape of bispecific antibodies in the treatment of lung cancer · Current Opinion in Oncology · 2025 · Same journal
• Circulating tumor DNA in human papilloma virus negative head and neck squamous cell carcinoma · Current Opinion in Oncology · 2026 · Same journal
• Immunotherapy in rare histologies of breast cancer: challenges, opportunities, and future perspectives · Current Opinion in Oncology · 2025 · Same journal
• Emerging role of functional imaging in renal cell carcinoma: from morphology to molecular phenotyping with PET/computed tomography · Current Opinion in Oncology · 2026 · Same journal
• Desmoplastic small round cell tumor · Current Opinion in Oncology · 2026 · Same journal
• Conducting clinical trials in supportive and palliative oncology: challenges and opportunities · Current Opinion in Oncology · 2026 · Same journal